期刊
PHARMACOTHERAPY
卷 31, 期 12, 页码 37S-43S出版社
WILEY
DOI: 10.1592/phco.31.12.37S
关键词
type 2 diabetes mellitus; treatment options; guidelines; glycemic control; insulin
资金
- Idaho State University
- Novo Nordisk Inc.
- International Society for Medical Publication Professionals' Good Publication Practice for Communicating Company
The number of novel treatment options for type 2 diabetes mellitus, including those with distinctive mechanisms of action, has risen sharply this decade, and health care providers must be aware of the drugs' safety and efficacy in order to provide patients with the best care possible. Guidelines for type 2 diabetes provide recommendations for initiating and continuing treatment that will enable patients to achieve glycemic control and maintain it over time. Several recently completed, large clinical trials have provided information pertaining to potential benefits and risks of achieving specific treatment goals, and medical professionals should consider applying the insights from these trials when optimizing care for their patients. The pharmacist plays an essential role in helping patients achieve and maintain tight glycemic control by assisting other health care providers in understanding and utilizing the guidelines as part of individualized treatment regimens.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据